CORE LABORATORIES INC(CLB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CLB CORE LABORATORIES INC

Not Yet Opened 03-19 16:00:00 EDT

15.97

-0.09

-0.56%

盘后15.97

+0.000.00%

19:30 EDT

High16.36	Low15.81	Vol371.52K
Open15.90	D1 Closing16.06	Amplitude3.42%
Mkt Cap743.62M	Tradable Cap740.74M	Total Shares46.56M
T/O5.94M	T/O Rate0.80%	Tradable Shares46.38M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CLB","market":"US","secType":"STK","nameCN":"CORE LABORATORIES INC","latestPrice":15.97,"timestamp":1773950400000,"preClose":16.06,"halted":0,"volume":371522,"hourTrading":{"tag":"盘后","latestPrice":15.97,"preClose":15.97,"latestTime":"19:30 EDT","volume":11203,"amount":178912.22,"timestamp":1773963019564,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.005603985056039732,"floatShares":46383411,"shares":46563387,"eps":0.676256,"marketStatus":"Not Yet Opened","change":-0.09,"latestTime":"03-19 16:00:00 EDT","open":15.9,"high":16.36,"low":15.81,"amount":5944402.898514,"amplitude":0.034247,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.676256,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773993600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":811656000000,"exchange":"NYSE","adjPreClose":16.06,"dividendRate":0.002505,"preHourTrading":{"tag":"盘前","latestPrice":16.22,"preClose":16.06,"latestTime":"09:01 EDT","volume":816,"amount":13667.10648,"timestamp":1773925268637,"change":0.16,"changeRate":0.009963,"amplitude":0.070984},"postHourTrading":{"tag":"盘后","latestPrice":15.97,"preClose":15.97,"latestTime":"19:30 EDT","volume":11203,"amount":178912.22,"timestamp":1773963019564,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.105717,"impliedVol":0.6919,"impliedVolPercentile":0.753},"requestUrl":"/m/hq/s/CLB/wiki","defaultTab":"wiki","newsList":[{"id":"2620423925","title":"Core Laboratories files 8-K/A correcting 2025 income tax expense by USD 4.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620423925","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620423925?lang=en_us&edition=fundamental","pubTime":"2026-03-17 18:16","pubTimestamp":1773742593,"startTime":"0","endTime":"0","summary":"Core Laboratories filed an amended Form 8-K to correct financial information in its earnings release for the quarter and year ended Dec. 31, 2025. The company said estimated income tax expense for that period was understated by 4.2 million, reducing net income by the same amount. It also reported immaterial balance sheet corrections as of Dec. 31, 2024, including a 4.7 million misclassification between income taxes receivable and deferred tax liabilities. Core Laboratories also recorded a 5.6 million write-off of unrecoverable income taxes receivable, reflected as an adjustment to beginning retained earnings. The company said the tax expense correction did not change consolidated revenue, operating income, income before tax, or cash from operations as previously presented.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL9fmtPb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLB","BK4179"],"gpt_icon":0},{"id":"2617557665","title":"Core Laboratories Lowers Shareholder Voting Threshold to Simple Majority","url":"https://stock-news.laohu8.com/highlight/detail?id=2617557665","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617557665?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:12","pubTimestamp":1772745149,"startTime":"0","endTime":"0","summary":"Core Laboratories Inc. said its board approved and adopted amended and restated bylaws effective Feb. 27, 2026, lowering the voting threshold in Section 2.11 for certain shareholder actions, including mergers and change-in-control transactions. The required vote was reduced from a 66-2/3% supermajority to a 50% plus one simple majority.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Laboratories Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDLccP0XT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","CLB"],"gpt_icon":0},{"id":"2616370985","title":"Core Laboratories Delays Filing of 2025 Annual Report on Form 10-K","url":"https://stock-news.laohu8.com/highlight/detail?id=2616370985","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616370985?lang=en_us&edition=fundamental","pubTime":"2026-03-04 06:45","pubTimestamp":1772577949,"startTime":"0","endTime":"0","summary":"Core Laboratories Inc. filed a Form 12b-25 late filing notice saying it will not be able to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The company said it needs additional time for accounting analyses and documentation related to complex multi-jurisdiction income tax matters and to complete its evaluation of internal controls, noting the review could result in a material non-cash impact to financial statements, though the amount cannot yet be determined.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Laboratories Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL13Wg7b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","CLB"],"gpt_icon":0},{"id":"2609931979","title":"BRIEF-Core Laboratories Expects Q1 Rev Between $124 Mln To $130 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2609931979","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609931979?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:24","pubTimestamp":1770243848,"startTime":"0","endTime":"0","summary":"BRIEF-Core Laboratories Expects Q1 Rev Between $124 Mln To $130 MlnFeb 4  - Core Laboratories Inc CLB.N:CORE LABORATORIES INC OUTLOOK Q1 REVENUE IS PROJECTED TO RANGE FROM $124 MILLION TO $130 MILLIONCORE LABORATORIES INC - REPORTS Q4 REVENUE OF $138.3 MILLION - SEC FILINGCORE LABORATORIES INC: Q4 EPS $0.15CORE LABORATORIES INC: WEATHER-RELATED DISRUPTIONS HAVE CREATED ADDITIONAL REVENUE AND MARGIN HEADWINDS FOR Q1CORE LABORATORIES INC OUTLOOK Q1 EPS $0.11 TO $0.15 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nL8N3Z03B1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLB","BK4179"],"gpt_icon":0},{"id":"2609031924","title":"Corrected-Core Laboratories Inc Outlook Q1 Revenue Is Projected to Range From $124 Mln to $130 Mln (Not $82 Mln to $86 Mln)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609031924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609031924?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:24","pubTimestamp":1770243846,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nL8N3Z03B1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4179","CLB"],"gpt_icon":0},{"id":"2609319292","title":"Oilfield services firm Core Laboratories' Q4 revenue rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2609319292","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609319292?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:23","pubTimestamp":1770243832,"startTime":"0","endTime":"0","summary":"Oilfield services firm Core Laboratories' Q4 revenue risesOverviewOilfield services firm's Q4 revenue rose 7% yr/yrCompany repurchased 363,207 shares for $5.7 mlnOutlookCore Laboratories projects Q1 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nL1N3Z01JQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLB","BK4179"],"gpt_icon":0},{"id":"2609319934","title":"BRIEF-Core Laboratories Q4 EPS USD 0.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2609319934","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609319934?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:16","pubTimestamp":1770243393,"startTime":"0","endTime":"0","summary":"BRIEF-Core Laboratories Q4 EPS USD 0.15\n\n\nFeb 04 (Reuters) - Core Laboratories Q4 revenue USD 138.3 million.\n\noutlook Q1 EPS USD 0.11-0.15","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nPLX7090FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","CLB"],"gpt_icon":0},{"id":"2609319996","title":"Core Laboratories Outlook Q1 EPS USD 0.11-0.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2609319996","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609319996?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:15","pubTimestamp":1770243348,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nPLX7090FF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4179","CLB"],"gpt_icon":0},{"id":"2609319412","title":"Core Laboratories: Expects Seasonal Patterns to Result in Typical Sequential Decline in Activity During Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2609319412","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609319412?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:15","pubTimestamp":1770243348,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nPLX7090FF:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4179","CLB"],"gpt_icon":0},{"id":"2609204316","title":"Core Laboratories Q4 Adj. EPS $0.21 Beats $0.19 Estimate, Sales $138.255M Beat $131.100M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2609204316","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609204316?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:00","pubTimestamp":1770242401,"startTime":"0","endTime":"0","summary":"Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.19 by 11.11 percent. This is a 4.55 percent decrease over earnings of $0.22 per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50397884/core-laboratories-q4-adj-eps-0-21-beats-0-19-estimate-sales-138-255m-beat-131-100m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","CLBR U","CLB"],"gpt_icon":0},{"id":"2609931988","title":"Core Laboratories Inc Outlook Q1 Revenue Is Projected to Range From $82 Mln to $86 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2609931988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609931988?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:59","pubTimestamp":1770242396,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nFWN3Z01IB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4179","CLB"],"gpt_icon":0},{"id":"2609731672","title":"Core Laboratories Inc: Q4 EPS $0.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2609731672","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609731672?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:59","pubTimestamp":1770242396,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nFWN3Z01IB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4179","CLB"],"gpt_icon":0},{"id":"2609319801","title":"Core Laboratories Inc Outlook Q1 EPS $0.11 to $0.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2609319801","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609319801?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:59","pubTimestamp":1770242396,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nFWN3Z01IB:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4179","CLB"],"gpt_icon":0},{"id":"2609316000","title":"Core Laboratories Inc: Weather-Related Disruptions Have Created Additional Revenue and Margin Headwinds for Q1","url":"https://stock-news.laohu8.com/highlight/detail?id=2609316000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609316000?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:59","pubTimestamp":1770242396,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nFWN3Z01IB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLB","BK4179"],"gpt_icon":0},{"id":"2609167123","title":"Core Lab steigert Umsatz im vierten Quartal (Q4) 2025 auf 138,26 Mio. USD, plus 7,0 Prozent","url":"https://stock-news.laohu8.com/highlight/detail?id=2609167123","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609167123?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:59","pubTimestamp":1770242381,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Laboratories Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL50hnNN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","CLB"],"gpt_icon":0},{"id":"2608500223","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2608500223","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608500223?lang=en_us&edition=fundamental","pubTime":"2026-02-04 19:00","pubTimestamp":1770202800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Blue Bird Corp                                  1Q       .79    4:01 PM. ·Bunge Global SA                                   4Q      1.81    6:00 AM. ·CME Grp Inc                                      4Q      2.75    7:00 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATEN","ATS","CENT","ACB","CDW","ALL","KMT","AZTA","CENTA","EG","CME","AMSC","AVB","BKH","AVY","GOOGL","ENS","DHX","BG","CLB","COR","DGII","GOOG","CCK","CCI","EFX","AFL","BSBR","ADNT","BOOT","BCH","ARCC","CMP","ABBV","CTSH","BLBD","EGP","ELF","DHT","BSX","ALGT","ALGN","ASGN","CRNC","BAM","CPAY"],"gpt_icon":1},{"id":"2602546204","title":"Core Laboratories price target raised to $11.50 from $10 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2602546204","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602546204?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:32","pubTimestamp":1768228329,"startTime":"0","endTime":"0","summary":"BofA raised the firm’s price target on Core Laboratories (CLB) to $11.50 from $10 and keeps an Underperform rating on the shares. Ex-M&A, the firm’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/core-laboratories-price-target-raised-to-11-50-from-10-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/core-laboratories-price-target-raised-to-11-50-from-10-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4179","CLB"],"gpt_icon":0},{"id":"2601837812","title":"Core Laboratories Inc. to Host Fourth Quarter Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2601837812","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601837812?lang=en_us&edition=fundamental","pubTime":"2026-01-06 05:06","pubTimestamp":1767647176,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Laboratories Inc. published the original content used to generate this news brief via PR Newswire  on January 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL6kV7bF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","CLB"],"gpt_icon":0},{"id":"2588703087","title":"Undiscovered Gems in the US Market to Explore December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588703087","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588703087?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:03","pubTimestamp":1764608620,"startTime":"0","endTime":"0","summary":"As December 2025 unfolds, the U.S. stock market is experiencing a cautious start with major indices like the Dow Jones, Nasdaq, and S&P 500 slipping amid a risk-off sentiment that has particularly impacted big tech and crypto-tied shares. Despite this broader market hesitance, opportunities may arise in lesser-known small-cap stocks that exhibit strong fundamentals and growth potential, often overlooked during periods of heightened volatility.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/3041000-choice2-main-header/1585186777117","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3041000-choice2-main-header/1585186777117"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nasdaq-nwpx/nwpx-infrastructure/news/undiscovered-gems-in-the-us-market-to-explore-december-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nasdaq-nwpx/nwpx-infrastructure/news/undiscovered-gems-in-the-us-market-to-explore-december-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4179","IE0031619046.USD","BK4129","NWPX","IE00B7SZL793.SGD","CLB","NVEC","BK4141","IE00B66KJ199.SGD","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2577958127","title":"Core Laboratories Gains as 4Q View Looks Insulated from Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2577958127","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577958127?lang=en_us&edition=fundamental","pubTime":"2025-10-24 00:18","pubTimestamp":1761236280,"startTime":"0","endTime":"0","summary":"Core Laboratories shares climbed after the energy-services company gave strong fourth-quarter guidance and said new tariff measures likely won't apply to most of its revenue sources.The stock jumped 28%, to $16.36, on Thursday. Shares are still down 7% this year.The company said it expects fourth-quarter revenue to be $132 million to $136 million, which would be ahead of the $128.6 million analysts were projecting, according to FactSet. Earnings per share are guided to be 18 cents to 22 cents, while analysts were forecasting 19 cents.Core Laboratories believes the tariffs under consideration won't apply to the vast majority of its service revenue and product sales, it said. Services account for more than 75% of the Houston company's total revenue and currently aren't subject to tariffs.Product sales have made up less than a quarter of total revenue and are primarily manufactured in the U.S. Tariffs on exported goods wouldn't apply to about half of those product sales, as they are consu","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","CLB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corelab.com","stockEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":-0.1483},{"period":"3month","weight":-0.0166},{"period":"6month","weight":0.3342},{"period":"1year","weight":0.0384},{"period":"ytd","weight":-0.0037}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0338},{"period":"3month","weight":-0.0305},{"period":"6month","weight":-0.0059},{"period":"1year","weight":0.1634},{"period":"ytd","weight":-0.0324}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, hydrogen storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. The company was founded in 1936 and is based in Houston, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.516129,"avgChangeRate":0.02468},{"month":2,"riseRate":0.580645,"avgChangeRate":0.015121},{"month":3,"riseRate":0.612903,"avgChangeRate":0.015977},{"month":4,"riseRate":0.6,"avgChangeRate":0.065653},{"month":5,"riseRate":0.466667,"avgChangeRate":0.013038},{"month":6,"riseRate":0.6,"avgChangeRate":-0.000791},{"month":7,"riseRate":0.333333,"avgChangeRate":0.001271},{"month":8,"riseRate":0.466667,"avgChangeRate":-0.028917},{"month":9,"riseRate":0.566667,"avgChangeRate":0.016408},{"month":10,"riseRate":0.516129,"avgChangeRate":0.024659},{"month":11,"riseRate":0.451613,"avgChangeRate":0.015701},{"month":12,"riseRate":0.516129,"avgChangeRate":0.014126}],"exchange":"NYSE","name":"CORE LABORATORIES INC","nameEN":"CORE LABORATORIES INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CORE LABORATORIES INC(CLB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CORE LABORATORIES INC(CLB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CORE LABORATORIES INC,CLB,CORE LABORATORIES INC股票,CORE LABORATORIES INC股票老虎,CORE LABORATORIES INC股票老虎国际,CORE LABORATORIES INC行情,CORE LABORATORIES INC股票行情,CORE LABORATORIES INC股价,CORE LABORATORIES INC股市,CORE LABORATORIES INC股票价格,CORE LABORATORIES INC股票交易,CORE LABORATORIES INC股票购买,CORE LABORATORIES INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CORE LABORATORIES INC(CLB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CORE LABORATORIES INC(CLB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction